SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biologics

PUBLISHER: Grand View Research | PRODUCT CODE: 2112263

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2112263

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain Logistics, Non-cold Chain Logistics), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Biopharmaceutical Third-Party Logistics Market Summary

The global biopharmaceutical third-party logistics market size was valued at USD 152.0 billion in 2025 and is projected to grow from USD 161.4 billion in 2026 to USD 258.4 billion by 2033, at a CAGR of 6.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 41.7% in 2025. The biopharmaceutical third-party logistics (3PL) industry is experiencing robust growth, driven by the expanding commercialization of biologics and biosimilars, increasing demand for temperature-controlled and GDP-compliant logistics infrastructure, rising outsourcing of supply chain operations by pharmaceutical and biotechnology companies, growth in clinical trials and advanced therapies including cell and gene therapies, and continuous investments in digital supply chain technologies for end-to-end product visibility and regulatory compliance.

The increasing complexity of global biopharmaceutical distribution, combined with stringent handling requirements for temperature-sensitive products and growing cross-border pharmaceutical trade, is encouraging manufacturers to partner with specialized third-party logistics providers offering integrated transportation, warehousing, packaging, inventory management, and cold chain capabilities.

The rapid expansion of biologics, biosimilars, and advanced therapies remains one of the primary factors driving market growth. Unlike conventional pharmaceuticals, biologics require specialized transportation, temperature-controlled storage, validated packaging, and continuous monitoring throughout the supply chain to preserve product efficacy and regulatory compliance. The growing commercialization of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies has significantly increased the demand for specialized logistics providers with GDP-certified infrastructure and global distribution networks.

Furthermore, increasing outsourcing of pharmaceutical supply chain operations is another major driver supporting market expansion. Pharmaceutical and biotechnology companies are increasingly relying on specialized third-party logistics providers to optimize distribution efficiency, improve regulatory compliance, reduce operational costs, and enhance supply chain resilience across global markets. Managing highly regulated biopharmaceutical supply chains requires specialized expertise in cold chain management, customs clearance, serialization, inventory control, and last-mile delivery, making outsourcing a cost-effective and scalable solution. Strategic investments and acquisitions across the logistics industry further demonstrate this trend. For instance, in March 2025, DHL announced the acquisition of specialty pharmaceutical logistics provider CryoPDP to strengthen its capabilities in clinical trial logistics, biopharma distribution, and cell and gene therapy transportation, further expanding its integrated healthcare logistics portfolio and specialized cold chain network.

However, the market growth is constrained by the high capital investment required for temperature-controlled infrastructure, stringent global regulatory compliance requirements, and the operational complexity associated with transporting highly sensitive biopharmaceutical products across international markets. Nevertheless, increasing commercialization of advanced therapies, expanding biologics pipelines, growing adoption of digital supply chain technologies, and continued investments in GDP-compliant cold chain infrastructure are expected to create substantial long-term opportunities for biopharmaceutical third-party logistics providers. The market is expected to maintain steady growth as pharmaceutical manufacturers increasingly outsource complex logistics operations to specialized partners capable of delivering secure, compliant, and globally integrated supply chain solutions.

Global Biopharmaceutical Third-party Logistics Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biopharmaceutical third-party logistics market report based on supply chain, service type, and region:

  • Supply Chain Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Cold Chain Logistics
  • Non-cold Chain Logistics
  • Service Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Other Services
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman
Show more
Product Code: GVR-2-68038-773-5

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Supply Chain
    • 1.2.2. Service Type
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopharmaceutical Third-Party Logistics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Logistics
      • 3.2.1.2. Growing Applications of Reverse Logistics in the Biopharmaceutical Industry
      • 3.2.1.3. Rising Demand for Cold Chain Logistics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance Issues While Outsourcing
      • 3.2.2.2. Stringent Regulatory Framework
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Biopharmaceutical Third-Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 4.1. Biopharmaceutical Third-Party Logistics Market, By Supply Chain: Segment Dashboard
  • 4.2. Biopharmaceutical Third-Party Logistics Market, By Supply Chain: Movement Analysis
  • 4.3. Biopharmaceutical Third-Party Logistics Market Estimates & Forecasts, By Supply Chain, 2021 - 2033 (USD Million/Billion)
  • 4.4. Cold Chain Logistics
    • 4.4.1. Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 4.5. Non-cold Chain Logistics
    • 4.5.1. Non-cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 5. Biopharmaceutical Third-Party Logistics Market: Service Type Estimates & Trend Analysis

  • 5.1. Biopharmaceutical Third-Party Logistics Market, By Service Type: Segment Dashboard
  • 5.2. Biopharmaceutical Third-Party Logistics Market, By Service Type: Movement Analysis
  • 5.3. Biopharmaceutical Third-Party Logistics Market Estimates & Forecasts, By Service Type, 2021 - 2033 (USD Million/Billion)
  • 5.4. Transportation
    • 5.4.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.4.2. Air Freight
      • 5.4.2.1. Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.4.3. Sea Freight
      • 5.4.3.1. Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.4.4. Overland
      • 5.4.4.1. Overland Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 5.5. Warehousing and Storage
    • 5.5.1. Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 5.6. Other Services
    • 5.6.1. Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 6. Biopharmaceutical Third-Party Logistics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2025 & 2033
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.6. Qatar
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.7. Oman
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Competitive Landscape

  • 7.1. Key Participant Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 7.3. Company Profiles
    • 7.3.1. DHL International GmbH
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. SF Express
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. FedEx
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. United Parcel Service of America, Inc.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Cencora, Inc.
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. DB Schenker
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Kuehne and Nagel
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Kerry Logistics Network Limited
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Agility Public Warehousing Company K.S.C.P.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
Show more
Product Code: GVR-2-68038-773-5

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million/Billion)
  • Table 4. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 5. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 6. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 7. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 8. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 9. U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 10. U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 11. Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 12. Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 13. Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 14. Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 15. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 16. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 17. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 18. UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 19. UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 20. Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 21. Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 22. France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 23. France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 24. Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 25. Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 26. Spain Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 27. Spain Biopharmaceutical Third-Party LogisticsMarket Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 28. Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 29. Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 30. Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 31. Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 32. Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 33. Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 34. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 35. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 36. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 37. Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 38. Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 39. China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 40. China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 41. India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 42. India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 43. Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 44. Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 45. South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 46. South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 47. Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 48. Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 49. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 50. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 51. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 52. Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 53. Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 54. Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 55. Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 56. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 57. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 58. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 59. South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 60. South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 61. Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 62. Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 63. UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 64. UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 65. Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 66. Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 67. Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 68. Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 69. Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 70. Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Biopharmaceutical Third-Party Logistics Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Biopharmaceutical Third-Party Logistics Market: Supply Chain outlook and key takeaways (USD Million/Billion)
  • Fig. 20 Biopharmaceutical Third-Party Logistics Market: Supply Chain movement analysis
  • Fig. 21 Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 22 Non-cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 23 Biopharmaceutical Third-Party Logistics Market: Service Type outlook and key takeaways (USD Million/Billion)
  • Fig. 24 Biopharmaceutical Third-Party Logistics Market: Service Type movement analysis
  • Fig. 25 Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 26 Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 27 Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 28 Overland Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 29 Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 30 Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 33 U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 34 Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 35 Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 36 Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 37 UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 38 Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 39 France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 40 Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 41 Spain Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 42 Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 43 Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 44 Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 45 Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 46 Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 47 China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 48 India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 49 Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 50 South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 51 Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 52 Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 53 Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 54 Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 55 Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 56 South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 57 Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 58 UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 59 Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 60 Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 61 Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!